In today's fast-paced technological advancements in medicine, the treatment of acute bacterial skin and skin structure infections (ABSSSI) has seen remarkable p ...

It is in the interest of patients, physicians, the drug industry and health regulatory bodies to prevent new nephrotoxic drugs from entering the market or, when the medical need dictates use of ...

In clinical practice, strategies to reduce nephrotoxicity due to specific drugs are usually based on the avoidance of established risk factors, such as high doses. However, effective prevention of ...

Antibiotics play a crucial role in combating bacterial infections, but their use, particularly in children, requires careful ...

The dose and duration of colistin therapy, baseline serum creatinine, change in level of creatinine after colistin therapy, other nephrotoxic antibiotics/drugs coadministered, and clinical and ...